Both Ontario and Québec are “catching up” to the rest of Canada with respect to the expanded scope of pharmacy practice. Work is underway in Ontario with the new registrar, Marshall Moleschi from British Columbia, and in Québec with new legislation on pharmacy practice just adopted. It is clear that the pace of change in pharmacy will persist through 2012.

Wayne Childs will be chairing eyeforpharma’s first Sales Excellence Canada event.

Helen Kalra from the Pangaea Group will be speaking as one of the conference’s chosen subject matter experts.

This article provides an overview of the key components of strategic plans, some best practices and biases to avoid. A winning process that includes the right people engaged in vigorous debate, avoiding biases, and making tough choices together with on-going monitoring of the environment to course correct, if necessary, will keep you focused on a winning strategic path.

Maximize the success of your brand. Learn how to grow your brand from experienced industry executives no matter where it is in its life cycle. Learn from experience.

Globally, over 60% of pharmaceutical industry growth can be attributed to specialty care brands. Pangaea recently interviewed a cross-range of executives in specialty and primary care pharmaceutical markets to understand how this market differs from primary care, what it takes to be successful and how the HR function can help ensure that success.

In their simplest form, SEBs are biologics — drugs created by bio- logical processes — with a demonstrated similarity to a previously approved biologic drug. Read more to find out how the regulatory environment and commercial models are unfolding and what impact is expected on the biologic market.

There has been a great deal of publicity on the new and expanded role of Pharmacists in the selection of pharmaceuticals across Canada. This article will clarify exactly what has changed and what the Pharmacist is empowered to do.

Quebec is undergoing its own transformation. This article highlights the changes and the implications for pharmaceuticals.

Executives in the hospital channel are dealing with significant and largely unmanageable forces that are shaping their decisions. In this atmosphere, it is important to know what senior health executives, who are now more involved in the buying decision, are looking for, in addition to good pricing.

We conducted research with 22 senior executives from 12 companies on the role of emotional intelligence (EI) in the Canadian research and development pharmaceutical industry, and the results were eye opening! We concluded there is a real risk that many companies are missing the boat on a genuine opportunity to gain a competitive edge.

Amgen approached Pangaea 11 years ago and asked that we provide strategic council and tactical support in the areas of business development, new product launches and distributor & pharmacy chain relations. When we were initially approached by Amgen, they wanted to establish a strong presence with channel customers and make sure their investments led to a tangible ROI. Our dedicated trade team of trade relations specialists assisted Amgen’s internal Supply Chain group to meet these goals.

The generic landscape has been evolving quickly over the past year and a half and Hoffmann-LaRoche Limited (Roche) needed some in depth expertise to explain where government policies were trending and what it meant for their specialty brands that were soon coming off patent.

Based on the positive outcomes of the many projects we had completed for them in the past, in 2008 Allergan assigned Pangaea with the ongoing task of managing their Rx Retail Trade requirements nationally.

September 2011’s Market Insight in Canadian Pharmaceutical Marketing finds Marc Lafoley exploring Subsequent Entry Biologics (SEBs) effect on regulatory approval, pricing and market dynamics.

Le 29 septembre 2011 de 8:00 à 10:00

When we were initially approached by Astellas, they had a specific problem: Managing their relationships with retailers and distributors.

Our dedicated team of trade relations specialists helped augment Astella’s marketing team and provide hands-on assistance.

September 22, 2011; 8:00 – 10:00AM